期刊文献+

西尼罗河病毒NS1的克隆、表达及抗原性分析 被引量:2

Cloning and expression of the NS1 gene encoding the non-structural protein Ⅰ of West Nile Virus and the analysis of its antigenicity
下载PDF
导出
摘要 目的克隆和表达西尼罗河病毒(WNV)非结构蛋白1(NS1),并分析其与登革病毒NS1的抗原交叉反应性。方法合成WNV NS1全基因序列,将NS1全基因克隆到pGEX-5X-3原核表达载体中表达GST-NS1融合蛋白,用4型登革病毒免疫血清及登革病毒NS1单克隆抗体并应用Western Blot方法分析WNV-NS1重组蛋白的抗原性。结果重组质粒pGEX-5X-3-WNV-NS1经IPTG诱导,高效表达GST-NS1融合蛋白,经变性纯化和复性获得可溶性WNV-NS1重组蛋白,经Western Blot证实WNV-NS1重组蛋白可与各型登革病毒免疫小鼠血清及部分4型登革病毒NS1交叉单抗识别。结论成功获得可溶性WNV-NS1重组蛋白,该蛋白与登革病毒NS1具有抗原交叉反应性,其结果为建立西尼罗河病毒的血清学诊断和鉴别诊断奠定了基础。 To clone and express the NS1 gene encoding the non-structural protein I of West Nile Virus (WNV) and to analyze the crossing reaction antigens with dengue fever virus, the whole NS1 gene sequence of WNV was synthesized and cloned to prokaryotic expression vector pGEX-SX-3 to express the GST-NS-1 fusion protein. Meanwhile, its antigenicity was analyzed by mouse antisera and monoclonal antibodies against 4 types of NS-1 proteins of dengue fever virus by Western blot assay. Experimental results demonstrated that the recombinant NS-1 protein could be highly expressed in E. coli BL21 and the soluble NS-1 protein could he recognized by the mouse antisera and the part of the crossing monoelonal antibodies against 4 types of NS-1 protein of dengue fever virus. These results would provide foundation for the establishment of the serological diagnosis and the differential diagnosis for WNV infection.
出处 《中国人兽共患病学报》 CAS CSCD 北大核心 2009年第6期545-548,共4页 Chinese Journal of Zoonoses
关键词 西尼罗河病毒 登革病毒 非结构蛋白 原核表达 west nile virus nonstructural protein prokaryotic expresstion
  • 相关文献

参考文献12

  • 1Solomon T,Ooi MH,Beasley DWC,et al.West Nile encephalitis[J].BMJ,2003.326:865-869.
  • 2Murgue B H,Zeller,V Deubel.The ecology and epidemiology of West Nile virus in Africa,Europe and Asia[J].Curr Top icrobiol Immunol,2002,267:195-221.
  • 3Hall RA,Broom AK,Smith DW,et al.The ecology and epidemiology of Kunjin virus[J].Curr Top Microbiol Immunol,2002,267:253-269.
  • 4Dauphin G,Zientara S,Zeller H,et al.West Nile:worldwide current situation in animals and humans[J].Comp Immunol Microbiol Infect Dis,Sep 2004,27(5):343-355.
  • 5Lindenbach B D,Rice C M.Flaviviridae:the viruses and their replicationFields virology,4th ed.,vol.1.Lippincott Williams & Wilkins,Philadelphia,Pa.2001,991-1041.
  • 6Joanne M,Tonry J,Hall R A,ed al.NS1 Protein Secretion during the Acute Phase of West Nile Virus Infection[J].J Virology,2005,79(22):13924-13933.
  • 7王新帅,丘立文,潘玉先,狄飙,车小燕.Ⅱ型登革病毒非结构蛋白NS1血清型特异性单克隆抗体的制备与鉴定[J].中国人兽共患病学报,2007,23(12):1176-1179. 被引量:1
  • 8晋晶,潘玉先,丁细霞,蔡建飘,狄飙,车小燕.Ⅲ型登革病毒NS1单克隆抗体的制备及鉴定[J].广东医学,2007,28(11):1726-1729. 被引量:5
  • 9廖志勇,王压娣,温坤,丘立文,狄飚,袁国勇,车小燕.禽流感病毒血凝素H5特异性单克隆抗体的制备及ELISA捕获法的建立[J].免疫学杂志,2007,23(3):339-343. 被引量:9
  • 10Sambrook J,Russell DW.分子克隆实验指南[M].3版.黄培堂,译.北京:科学出版社.2002:45-50.

二级参考文献34

  • 1丘立文,王压娣,廖志勇,梅亚波,车小燕.SARS-CoV、229E和OC43的抗原相关性研究[J].中国免疫学杂志,2006,22(8):691-695. 被引量:4
  • 2金冬雁 黎孟枫 等.分子克隆实验指南(第2版)[M].科学出版社,1993.24.
  • 3Lee E,Hall RA,Lobigs M.Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses.J Virol,2004,78:8271-8280.
  • 4Beasley DWC,Holbrook MR,Travassos da Rosa APA,et al.Use of a recombinant envelope protein subunit antigen for specific serological diagnosis of West Nile Virus infection.J Clin Microbiol,2004,42:2759-2765.
  • 5Volk DE,Beasley DWC,Kallick DA,et al.Solution structure and antibody binding studies of the envelope protein domain Ⅲ from the New York strain of West Nile Virus.J Biol Chem,2004,279:38755-38766.
  • 6Chu JJH,Rajamanonmani R,Li J,et al.Inhibition of West Nile virus entry by using a recombinant domain Ⅲ from the envelope glycoprotein.J Gen Virol,2005,86:405-412.
  • 7Lee JWM,Chu JJH,Ng ML.Quantifying the specific binding between West Nile virus envelope domain Ⅲ protein and the cellular receptor αVβ3 integrin.J Biol Chem,2006,281:1352-1360.
  • 8Solomon T,Ooi MH,Beasley DWC,et al.West Nile encephalitis.BMJ 2003,326:865-869.
  • 9Beasley DWC,Barrett ADT.Identification of neutralizing epitopes within structural domain Ⅲ of the West Nile Virus envelope protein.J Virol,2002,76:13097-13100.
  • 10Holbrook MR,Shope RE,Barrett ADT.Use of recombinant E protein domain Ⅲ-based enzyme-linked immunosorbent assays for differentiation of Tick-Borne encephalitis serocomplex flaviviruses from Mosquito-Borne flaviviruses.J Clin Microbiol,2004,42:4101-4110.

共引文献17

同被引文献16

  • 1刘艳丽,司炳银,祝庆余.森林脑炎疫苗研究进展[J].中国地方病学杂志,2005,24(3):351-353. 被引量:2
  • 2刘艳丽,司炳银,户义,张雨,杨银辉,祝庆余.森林脑炎病毒prM-E蛋白在昆虫细胞中的表达及免疫活性测定[J].中华实验和临床病毒学杂志,2005,19(4):335-339. 被引量:4
  • 3丘立文,王压娣,廖志勇,梅亚波,车小燕.SARS-CoV、229E和OC43的抗原相关性研究[J].中国免疫学杂志,2006,22(8):691-695. 被引量:4
  • 4Lu Z, Fu SH, Cao L, et al. Human infection with West Nile Virus, Xinjiang, China, 2011[J]. Emerg Infect Dis, 2014, 20(8): 1421-1423.
  • 5Li XL, Fu SH, Liu WB, et al. West Nile virus infection in Xinjiang, China [J].Vector Borne Zoonotic Dis, 2013, 13(2): 131-133.
  • 6Che XY, Qiu LW, Pan YX, et al. Sensitive and specific monoclonal antibody-based capture enzyme immunoassay for detection of nueleoeapsid antigen in sera from patients with severe acute respiratory syndrome[J]. J Clin Microbiol, 2004, 42(6): 2629-2635.
  • 7Oliphant T, Engle M, Nybakken GE, et al. Development of a humanized monoelonal antibody with therapeutic potential against West Nile virus[J]. Nat Med, 2005, 11(5):522-530.
  • 8Ben ND, Lustig S, Tam G, et al. Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice[J]. J Infect Dis, 2003, 188(1): 5-12.
  • 9Julander JG, Winger QA, Olsen AL, et al. Treatment of West Nile virus-infected mice with reactive immunoglobulin reduces fetal titers and increases dam survival[J]. Antiviral Res, 2005, 65(2): 79-85.
  • 10Young PR, Hilditch PA, Bletchly C, et al. An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients[J]. J Clin Microbiol, 2000, 38(3): 1053-1057.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部